目次

Executive Summary
Market Overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Drug class
Market segments
Comparison by Drug class
NSAIDs - Market size and forecast 2020-2025
Urate-lowering agents - Market size and forecast 2020-2025
Corticosteroids - Market size and forecast 2020-2025
Colchicine - Market size and forecast 2020-2025
Market opportunity by Drug class

Customer landscape
Customer landscape

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Overview
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
AstraZeneca Plc
Avion Pharmaceuticals LLC
Cadila Healthcare Ltd.
Hikma Pharmaceuticals Plc
Horizon Therapeutics Plc
Ironwood Pharmaceuticals Inc.
JW Pharmaceutical Corp.
Selecta Biosciences Inc.
Takeda Pharmaceutical Co. Ltd.
Teijin Ltd.

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Drug class - Market share 2020-2025 (%)
22: Comparison by Drug class
23: NSAIDs - Market size and forecast 2020-2025 ($ million)
24: NSAIDs - Year-over-year growth 2020-2025 (%)
25: Urate-lowering agents - Market size and forecast 2020-2025 ($ million)
26: Urate-lowering agents - Year-over-year growth 2020-2025 (%)
27: Corticosteroids - Market size and forecast 2020-2025 ($ million)
28: Corticosteroids - Year-over-year growth 2020-2025 (%)
29: Colchicine - Market size and forecast 2020-2025 ($ million)
30: Colchicine - Year-over-year growth 2020-2025 (%)
31: Market opportunity by Drug class
32: Customer landscape
33: Market share By Geographical Landscape 2020-2025 (%)
34: Geographic comparison
35: North America - Market size and forecast 2020-2025 ($ million)
36: North America - Year-over-year growth 2020-2025 (%)
37: Europe - Market size and forecast 2020-2025 ($ million)
38: Europe - Year-over-year growth 2020-2025 (%)
39: Asia - Market size and forecast 2020-2025 ($ million)
40: Asia - Year-over-year growth 2020-2025 (%)
41: ROW - Market size and forecast 2020-2025 ($ million)
42: ROW - Year-over-year growth 2020-2025 (%)
43: Key leading countries
44: Market opportunity By Geographical Landscape ($ million)
45: Impact of drivers and challenges
46: Vendor landscape
47: Landscape disruption
48: Industry risks
49: Vendors covered
50: Market positioning of vendors
51: AstraZeneca Plc - Overview
52: AstraZeneca Plc - Product and service
53: AstraZeneca Plc - Key offerings
54: AstraZeneca Plc - Key customers
55: AstraZeneca Plc - Segment focus
56: Avion Pharmaceuticals LLC - Overview
57: Avion Pharmaceuticals LLC - Product and service
58: Avion Pharmaceuticals LLC - Key offerings
59: Avion Pharmaceuticals LLC - Key customers
60: Avion Pharmaceuticals LLC - Segment focus
61: Cadila Healthcare Ltd. - Overview
62: Cadila Healthcare Ltd. - Business segments
63: Cadila Healthcare Ltd. - Key offerings
64: Cadila Healthcare Ltd. - Key customers
65: Cadila Healthcare Ltd. - Segment focus
66: Hikma Pharmaceuticals Plc - Overview
67: Hikma Pharmaceuticals Plc - Business segments
68: Hikma Pharmaceuticals Plc - Key offerings
69: Hikma Pharmaceuticals Plc - Key customers
70: Hikma Pharmaceuticals Plc - Segment focus
71: Horizon Therapeutics Plc - Overview
72: Horizon Therapeutics Plc - Business segments
73: Horizon Therapeutics Plc - Key offerings
74: Horizon Therapeutics Plc - Key customers
75: Horizon Therapeutics Plc - Segment focus
76: Ironwood Pharmaceuticals Inc. - Overview
77: Ironwood Pharmaceuticals Inc. - Business segments
78: Ironwood Pharmaceuticals Inc. - Key offerings
79: Ironwood Pharmaceuticals Inc. - Key customers
80: Ironwood Pharmaceuticals Inc. - Segment focus
81: JW Pharmaceutical Corp. - Overview
82: JW Pharmaceutical Corp. - Product and service
83: JW Pharmaceutical Corp. - Key offerings
84: JW Pharmaceutical Corp. - Key customers
85: JW Pharmaceutical Corp. - Segment focus
86: Selecta Biosciences Inc. - Overview
87: Selecta Biosciences Inc. - Product and service
88: Selecta Biosciences Inc. - Key offerings
89: Selecta Biosciences Inc. - Key customers
90: Selecta Biosciences Inc. - Segment focus
91: Takeda Pharmaceutical Co. Ltd. - Overview
92: Takeda Pharmaceutical Co. Ltd. - Product and service
93: Takeda Pharmaceutical Co. Ltd. - Key offerings
94: Takeda Pharmaceutical Co. Ltd. - Key customers
95: Takeda Pharmaceutical Co. Ltd. - Segment focus
96: Teijin Ltd. - Overview
97: Teijin Ltd. - Business segments
98: Teijin Ltd. - Key offerings
99: Teijin Ltd. - Key customers
100: Teijin Ltd. - Segment focus
101: Currency conversion rates for US$
102: Research Methodology
103: Validation techniques employed for market sizing
104: Information sources
105: List of abbreviations